10/28
08:09 am
coll
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
Low
Report
Collegium Pharmaceutical (NASDAQ:COLL) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $46.00 price target on the stock.
10/28
05:29 am
coll
Rating for COLL
Low
Report
Rating for COLL
10/28
05:29 am
coll
Rating for COLL
Low
Report
Rating for COLL